Aquestive Therapeutics, Inc. (AQST) Insider Trading
Over the last 3 months, AQST insiders made 0 open-market buys and 3 sales, a net sale of -$265K (SEC Form 4). Over the last 6 months, 130 institutions increased and 86 reduced their position (13F).
Insider Activity
Sentiment
0/100
Buys (3m)
0
Sells (3m)
3
Net (3m)
-$264.8K
Insider trades by month Buys Sells
Nov
Sep
Oct
Mar
May
Jun
Context3-month price +0.2%Institutions accumulating (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jun 24, 2026 | Krop Juliedirector | Option | 25,000 | $0.71 |
| Jun 24, 2026 | Krop Juliedirector | Sell | 25,000 | $5.02 |
| Jun 16, 2026 | Barber Danielofficer: President and CEO | Sell | 25,000 | $4.16 |
| Jun 12, 2026 | Taglietti Marcodirector | Grant | 50,500 | $3.99 |
| Jun 12, 2026 | MORRIS TIMOTHY Edirector | Grant | 50,500 | $3.99 |
| Jun 12, 2026 | Krop Juliedirector | Grant | 50,500 | $3.99 |
| Jun 12, 2026 | Jenkins Abigail L.director | Grant | 50,500 | $3.99 |
| Jun 12, 2026 | Cochran Johndirector | Grant | 50,500 | $3.99 |
| Jun 12, 2026 | BROWN GREGORY Bdirector | Grant | 50,500 | $3.99 |
| Jun 9, 2026 | Korczynski Sherryofficer: Chief Commercial Officer | Tax | 2,714 | — |
| May 19, 2026 | Zalewski Thomas A.officer: Chief Legal Officer | Grant | 100,000 | — |
| May 19, 2026 | Zalewski Thomas A.officer: Chief Legal Officer | Grant | 75,000 | $4.13 |
| May 18, 2026 | Barber Danielofficer: President and CEO | Sell | 8,257 | $4.29 |
| May 18, 2026 | Cioffi Melinaofficer: SVP, Regulatory Affairs | Tax | 1,667 | $4.17 |
| May 11, 2026 | BRAENDER LORI Jofficer: Corporate Secretary | Tax | 135,690 | $4.23 |
| May 7, 2026 | Barber Danielofficer: President and CEO | Tax | 335,922 | $4.18 |
| May 7, 2026 | Jung Cassieofficer: Chief Operating Officer | Tax | 72,734 | $4.18 |
| May 7, 2026 | BRAENDER LORI Jofficer: Corporate Secretary | Tax | 76,147 | $4.18 |
| May 7, 2026 | Boyd Peter E.officer: Chief People Officer | Tax | 56,778 | $4.18 |
| May 7, 2026 | TOTH A ERNEST JRofficer: Chief Financial Officer | Tax | 92,652 | $4.18 |
| Apr 13, 2026 | Jung Cassieofficer: Chief Operating Officer | Grant | 60,000 | — |
| Apr 13, 2026 | TOTH A ERNEST JRofficer: SVP, Chief Financial Officer | Grant | 82,500 | — |
| Apr 13, 2026 | Korczynski Sherryofficer: Chief Commercial Officer | Grant | 67,500 | — |
| Apr 13, 2026 | BRAENDER LORI Jofficer: Corporate Secretary | Grant | 82,500 | — |
| Apr 13, 2026 | Barber Danielofficer: President and CEO | Grant | 293,100 | — |
| Apr 13, 2026 | Boyd Peter E.officer: Chief People Officer | Grant | 60,000 | — |
| Mar 11, 2026 | Korczynski Sherryofficer: Chief Commercial Officer | Grant | 42,500 | $4.29 |
| Mar 11, 2026 | Korczynski Sherryofficer: Chief Commercial Officer | Sell | 15,741 | $4.17 |
| Mar 11, 2026 | Korczynski Sherryofficer: Chief Commercial Officer | Grant | 75,000 | — |
| Mar 11, 2026 | TOTH A ERNEST JRofficer: Chief Financial Officer | Grant | 70,000 | $4.29 |
Source: AQST SEC Form 4 filings, latest Jun 24, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their AQST positions over the last 6 months (SEC Form 13F).
Increased
130
New positions
97
Reduced
86
Sold out
71
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| BRATTON CAPITAL MANAGEMENT, L.P. | Unchanged | 9.8M | May 13, 2026 |
| BRATTON CAPITAL MANAGEMENT, L.P. | Unchanged | 9.8M | Feb 17, 2026 |
| BLACKROCK, INC. | Increased | 7.8M | Feb 12, 2026 |
| BLACKROCK, INC. | Reduced | 7.5M | May 13, 2026 |
| RTW INVESTMENTS, LP | Increased | 7.4M | May 15, 2026 |
| RTW INVESTMENTS, LP | Unchanged | 6.3M | Feb 17, 2026 |
| VANGUARD GROUP INC | Increased | 5.9M | Jan 29, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 4.4M | May 15, 2026 |
| FEDERATED HERMES, INC. | Increased | 2.9M | May 11, 2026 |
| BALYASNY ASSET MANAGEMENT L.P. | Increased | 2.9M | May 15, 2026 |
| ECOR1 CAPITAL, LLC | Unchanged | 2.6M | Feb 17, 2026 |
| STATE STREET CORP | Increased | 2.5M | May 15, 2026 |
| SAMSARA BIOCAPITAL, LLC | Unchanged | 2.5M | May 15, 2026 |
| SAMSARA BIOCAPITAL, LLC | Unchanged | 2.5M | Feb 17, 2026 |
| STATE STREET CORP | Increased | 2.5M | Feb 13, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.